Artelo Biosciences, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Armistice Capital, LLC and Steven Boyd have reported a 0.0% beneficial ownership of Artelo Biosciences, Inc. common stock, indicating a full divestment.
NASDAQ
Intracoastal Capital LLC, along with individuals Mitchell P. Kopin and Daniel B. Asher, reported a combined beneficial ownership of 4.8% in Artelo Biosciences, Inc. common stock as of June 30, 2026.
NASDAQ
Armistice Capital, LLC and Steven Boyd have reported beneficial ownership of 9.99% of Artelo Biosciences, Inc. common stock as of March 31, 2026.
NASDAQ
Intracoastal Capital LLC, along with individuals Mitchell P. Kopin and Daniel B. Asher, have disclosed a beneficial ownership stake of 9.99% in Artelo Biosciences, Inc.